Activity of tannins from Stryphnodendron adstringens on Cryptococcus neoformans: Effects on growth, capsule size and pigmentation

Annals of Clinical Microbiology and Antimicrobials

Volumn 8, Issue , 2009, Pages 29-

  Ishida, Kelly ^a   Rozental, Sonia ^a   de Mello, João C P ^b   Nakamura, Celso V ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TANNIN DERIVATIVE;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; ENZYME ACTIVITY; FRACTIONATION; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE EXPRESSION; MEDICINAL PLANT; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PIGMENTATION; STRYPHNODENDRON ADSTRINGENS; TRANSMISSION ELECTRON MICROSCOPY;

ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BRAZIL; CELL LINE, TUMOR; CHEMICAL FRACTIONATION; CRYPTOCOCCUS NEOFORMANS; FABACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; PIGMENTATION; TANNINS;

EID: 71149119411     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-8-29     Document Type: Article

References (39)

1. Martins ER, Castro DM, Castellani DC, Dias JD. Plantas Medicinais 1995, Imprensa Universitária, UFV, Viçosa, Brasil.
2. Farmacopéia Brasileira, Parte II, 4o fascículo: Barbatimão Barbadetimani cortex. Monografia 176, 4a ed., Atheneu, São Paulo 2002,
3. Palazzo de Mello JP, Petereit F, Nahrstedt A. Flavan-3-ols and prodelphinidins from Stryphnodendron adstringens. Phytochemistry 1996, 41:807-13.
4. Palazzo de Mello JP, Petereit F, Nahrstedt A. Prorobinetinidins from Stryphnodendron adstringens. Phytochemistry 1996, 42:857-62.
5. Panizza S, Rocha AB, Gecchi R, Silva RAP. Stryphnodendron barbadetiman (Vellozo) Martius: teor em tanino na casca e sua propriedade cicatrizante. Ver Cien Farm 1988, 10:101-6.
6. Bersani-Amado CA, Nakamura CV, Nakamura TU, Martinez M, Mello JCP. Avaliação das atividades antiinflamatória e antibacteriana do extrato bruto do Stryphnodendron adstringens (Barbatimão) [abstract]. 1996, 14. Abstracts of Simpósio de Plantas Medicinais do Brasil, Universidade Federal de Santa Catarina, Florianópolis.
7. Lima JCS, Martins DTO, De Souza PT. Experimental evaluation of stem bark of Stryphnodendron adstringens (Mart.) Coville foranti-inflammatory activity. Phytother Res 1998, 12:218-20.
8. Audi EA, Toledo DP, Peres PG, Kimura E, Pereira WKV, Mello JCP, Nakamura CV, Alves-do-Prado W, Cuman RKN, Bersani-Amado CA. Gastric antiulcerogenic effects of Stryphnodendron adstringens in rats. Phytother Res 1999, 13:264-6. 10.1002/(SICI)1099-1573(199905)13:3<264::AID-PTR443>3.0.CO;2-R, 10353177.
9. Holetz FB, Ueda-Nakamura T, Dias Filho BP, Mello JCP, Morgado-Díaz JA, Toledo CEM, Nakamura CV. Biological effects of extracts obtained from Stryphnodendron adstringens on Herpetomonas samuelpessoai. Mem Inst Oswaldo Cruz 2005, 100:397-401. 10.1590/S0074-02762005000400010, 16113888.
10. Herzog-Soares JDA, Alves R, Isac E, Bezerra JC, Gomes MH, Santos SC, Ferri PH. Atividade tripanocida in vivo de Stryphnodendron adstringens (barbatimão verdadeiro) e Caryocar brasiliensis (pequi). Rev Bras Farmacogn 2002, 12(Suppl 1):1-2.
11. Luize PS, Tiuman TS, Morello LG, Maza PK, Ueda-Nakamura T, DiasFilho BP, Cortez DAG, Mello JCP, Nakamura CV. Effects of medicinal extracts on growth of Leishmania (L.) amazonensis and Trypanosoma cruzi. Braz J Pharm Sciences 2005, 41:1-10.
12. Felipe AM, Rincão VP, Benati FJ, Linhares RE, Galina KJ, Toledo CE, Lopes GC, Mello JC, Nozawa C. Antiviral Effect of Guazuma ulmifolia and Stryphnodendron adstringens on Poliovirus and Bovine Herpesvirus. Biol Pharm Bull 2006, 29:1092-5. 10.1248/bpb.29.1092, 16754999.
13. Ishida K, Mello JC, Cortez DA, Dias Filho BP, Ueda-Nakamura T, Nakamura CV. Influence of tannins from Stryphnodendron adstringens on growth and virulence factors of Candida albicans. J Antimicrob Chemother 2006, 58:942-9. 10.1093/jac/dkl377, 16973655.
14. Lin X, Heitman J. The biology of the Cryptococcusneoformans species complex. Annu Rev Microbiol 2006, 60:69-105. 10.1146/annurev.micro.60.080805.142102, 16704346.
15. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000, 30:710-8. 10.1086/313757, 10770733.
16. Archibald LK, Tuohy MJ, Wilson DA, Nwanyanwu O, Kazembe PN, Tansuphasawadikul S, Eampokalap B, Chaovavanich A, Reller LB, Jarvis WR, Hall GS, Procop GW. Antifungal susceptibilities of Cryptococcus neoformans. Emerg Infect Dis 2004, 10:143-5.
17. Steenbergen JN, Casadevall A. The origin and maintenanceof virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 2003, 5:667-75. 10.1016/S1286-4579(03)00092-3, 12787743.
18. Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 2006, 50:3519-28. 1635213, 17065617, 10.1128/AAC.00545-06.
19. Fromtling RA, Shadomy HJ, Jacobson ES. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia 1982, 79:23-9. 10.1007/BF00636177, 6750405.
20. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A23, CLSI, Villanova, PA, USA 2008,
21. Barrett D. From natural products to clinically useful antifungals. Biochim Biophys Acta 2002, 1587:224-33.
22. Abad MA, Ansuategui M, Bermejo P. Active antifungal from natural sources. Arkivoc 2007, 116-45.
23. Baba M, Takeshige G, Baba N, Ohsumi Y. Ultrastructural analysis of the autophagic process in yeast: Detection of autophagosomes and their characterization. J Cell Biol 1994, 124:903-13. 2119983, 8132712, 10.1083/jcb.124.6.903.
24. Rodrigues JFC, De Souza W. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors. Curr Pharm Des 2008, 9:925-38.
25. Veneault-Fourrey C, Talbot NJ. Autophagic cell death and its importance for fungal development biology and pathogenesis. Autophagy 2007, 3:126-7.
26. Hu G, Hacham M, Waterman SR, Panepinto J, Shin S, Liu X, Gibbons J, Valyi-Nagy T, Obara K, Jaffe HA, Ohsumi Y, Williamson PR. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J Clin Invest 2008, 118:1186-97. 2230655, 18259613, 10.1172/JCI32053.
27. Masperi P, Dall'Olio G, Calefano A, Vannini GL. Autophagic vacuole development in Trichophyton mentagrophytes exposed in vitro to miconazole. Med Micol 1984, 22:27-35.
28. Pancaldi S, Dall'Olio G, Poli F, Fasulo MP. Stimulation of the autophagic activity in blastospores of Candida albicans exposed in vitro to fluconazole. Microbios 1994, 80:55-61.
29. Phillips AJ, Sudbery I, Ramsdale M. Apoptosis induced byenvironmental stress and amphotericin B in Candida albicans. Proc Natl Acad Sci USA 2003, 100:14327-32. 283591, 14623979, 10.1073/pnas.2332326100.
30. Cowan MM. Plant products antimicrobial agents. Clin Microbiol Rev 1999, 12:564-82. 88925, 10515903.
31. Haslam E. Natural polyphenols (vegetable tannins) as drugs: Possible modes of action. J Nat Prod 1996, 59:205-15. 10.1021/np960040+, 8991956.
32. Field JA, Lettinga G. Toxicity of tannic compounds to microorganisms. Plant polyphenols 1992, 673-89. New York: Plenum Press, Hemingway RW, Laks PE.
33. Scalbert A. Antimicrobial proprieties of tannins. Phytochemistry 1991, 30:3875-83.
34. Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M, Casadevall A. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal tran-cell wall transport. Eukaryot Cell 2007, 6:48-59. 1800364, 17114598, 10.1128/EC.00318-06.
35. Nimrichter L, Frases S, Cinelli LP, Viana NB, Nakouzi A, Travassos LR, Casadevall A, Rodrigues ML. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell 2007, 6:1400-10. 1951138, 17573547, 10.1128/EC.00122-07.
36. He Q, Shi B, Yao K. Interactions of gallotannins with proteins, amino acids, phospholipids and sugars. Food Chem 2006, 95:250-4.
37. Eisenman HC, Nosanchuk JD, Webber JB, Emerson RJ, Camesano TA, Casadevall A. Microstructure of cell wall-associated melaninin the human pathogenic fungus Cryptococcus neoformans. Biochemistry 2005, 44:3683-93. 10.1021/bi047731m, 15751945.
38. Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, Almeida IC, Casadevall A. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell 2008, 7:58-67. 2224146, 18039940, 10.1128/EC.00370-07.
39. Baurin N, Arnoult E, Scior T, Do QT, Bernard P. Preliminary screening of some tropical plants for anti-tyrosinase activity. J Ethnopharmacol 2002, 82:155-8. 10.1016/S0378-8741(02)00174-5, 12241990.